John Vanden Heuvel

Dr. John (Jack) Vanden Heuvel is one of The Company’s original founders, and currently serves as Chief Scientific Officer. Dr. Vanden Heuvel is a recognized expert in the field of nuclear receptor biology and toxicology with over 100 peer-reviewed publications. In addition to his role as CSO at INDIGO, Dr. Vanden Heuvel is a Professor at Penn State University where he is Program Coordinator of the undergraduate Toxicology Program, Co-Director of the Center of Excellence in Nutrigenomics and leads an extramurally funded research program.